share_log
Moomoo 24/7 ·  Mar 28 06:51
Kiora Pharmaceuticals to Present Additional Data From Its ABACUS-1 Trial Of KIO-301 in Retinitis Pigmentosa At ARVO 2024 Annual Meeting
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment